Trade Summary

4 months ago, Casdin Partners Master Fund, L.P., serving as Dir, 10% owner at Standard Biotools Inc. (LAB), purchased 525,000 shares at $1.25 per share, for a total transaction value of $658,798.00. Following this transaction, Casdin Partners Master Fund, L.P. now holds 79,859,918 shares of LAB.

This purchase represents a 1.00% increase in Casdin Partners Master Fund, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, August 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 26, 2025, 4 days after the trade was made.

Standard Biotools Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.